PROSTAGLANDINS & OTHER LIPID MEDIATORS, published by Elsevier Science Inc, is a leading journal dedicated to the advancements in the field of lipid mediators, with a specific focus on prostaglandins and other bioactive lipids. This journal, indexed under ISSN 1098-8823 and E-ISSN 2212-196X, serves as a crucial platform for researchers and professionals to disseminate significant findings that span multiple disciplines, including Biochemistry, Cell Biology, Pharmacology, and Physiology. In the 2023 category quartiles, it has achieved commendable positions such as Q2 in Biochemistry and Q2 in Physiology, underscoring its importance and influence in these domains. Although it is not an open-access journal, it provides robust access options, enhancing the visibility of vital research. With its establishment in 1996, the journal continues its commitment to fostering innovative research until 2024, making it an essential resource for those involved in the dynamic realms of lipid biology and medical research.

LIPIDS is a renowned peer-reviewed journal published by Wiley, dedicated to the field of lipid research, encompassing biochemistry, molecular biology, and organic chemistry. With its roots dating back to 1966 and a commitment to advancing knowledge until 2024, this journal serves as a vital platform for sharing significant findings in lipid biochemistry and its applications in health and disease. Although it currently does not offer Open Access options, it maintains a respectable standing with a Q3 ranking in Biochemistry and Organic Chemistry, and a Q4 ranking in Cell Biology based on the 2023 category quartiles. Additionally, its Scopus rankings reflect a solid position within the organic chemistry and biochemistry subfields. Published from Germany, LIPIDS caters to researchers, professionals, and students eager to explore the roles of lipids in biological processes and innovatory applications in various scientific disciplines.

OCL-Oilseeds and Fats Crops and Lipids is a renowned open-access journal published by EDP Sciences S A, specializing in the fields of agronomy, food science, and biochemistry. Since its inception in 2000, this journal has vigorously contributed to the advancement of research surrounding oilseeds and fats, addressing critical issues related to crop production, lipid analysis, and sustainable practices in food science. With an impressive impact factor reflected in its 2023 rankings—Q2 in Agronomy and Crop Science, Q3 in Biochemistry, and Q2 in Food Science—OCL stands out for its rigorous peer-review process and commitment to disseminating high-quality research. Its Scopus rankings further establish its reputation within the scientific community, occupying the 73rd and 64th percentiles in Agronomy and Food Science, respectively. This makes it an essential platform for researchers, professionals, and students focused on enhancing the understanding and application of lipid science and oilseed cultivation. Located in France, OCL encourages a global dialogue on innovations and discoveries that can drive the future of agricultural production and food technology.

Nature Metabolism, published by NATURE PORTFOLIO, is a leading journal dedicated to advancing the field of metabolic research and its implications across various biological systems. Since its inception in 2019, this esteemed journal has rapidly established itself as a vital resource for researchers, professionals, and students alike, reflecting its prominence through a prestigious Q1 ranking in several key categories including Cell Biology, Endocrinology, Diabetes and Metabolism, Internal Medicine, and Physiology. With an impressive Scopus ranking, underscoring its impact in Medicine and Biochemistry disciplines, Nature Metabolism offers an exceptional platform for disseminating high-quality research that explores the intricate mechanisms of metabolism and its association with health and disease. Although currently not open access, it continues to gain visibility and appreciation within the scientific community, ensuring that groundbreaking findings reach interested audiences globally from its hub in Berlin, Germany. Whether you are an experienced researcher or an aspiring student, Nature Metabolism serves as an invaluable asset in navigating the complexities of metabolic science.

Cancer & Metabolism is a distinguished open-access journal published by BMC, dedicated to advancing the understanding of the complex interactions between cancer biology and metabolic processes. Since its inception in 2013, it has provided a platform for researchers, clinicians, and students to disseminate groundbreaking research and innovative findings within the fields of oncology and metabolism. The journal, identified by its E-ISSN 2049-3002, is recognized for contributing valuable insights into metabolic alterations that influence cancer progression, treatment responses, and overall patient outcomes. With a firm commitment to open access, Cancer & Metabolism ensures that research is freely available to the global scientific community, fostering collaboration and accelerating discoveries that can lead to improved therapeutic strategies. As a vital resource in cancer research, this journal appeals to a broad audience, including researchers looking to share their latest findings, professionals seeking to stay informed on cutting-edge developments, and students eager to delve into the relationship between metabolism and cancer.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS is a distinguished peer-reviewed journal dedicated to advancing the understanding of the biological roles of prostaglandins, leukotrienes, and essential fatty acids in human health and disease. Published by Elsevier Science Ltd, this journal has been at the forefront of research since its inception in 1988 and continues to serve as a vital resource for researchers, clinicians, and students involved in the fields of biochemistry and cell biology. With its impact factor reflecting a solid academic presence—ranking Q3 in Cell Biology and Q2 in Clinical Biochemistry in 2023—this journal is recognized for its quality contributions, particularly in uncovering the biochemical pathways and clinical implications of these lipid mediators. Though not an open-access journal, it provides various access options to ensure the dissemination of critical findings. As the field evolves, PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS remains a pivotal platform for the exploration and discussion of new methodologies, therapeutic avenues, and biological discoveries that impact patient care and the foundational sciences.

Lipids in Health and Disease, published by BMC, stands as a leading open-access journal dedicated to advancing the understanding of lipid metabolism and its implications for health and disease. Since its inception in 2002, this journal has fostered accessibility to cutting-edge research, ensuring that knowledge in this vital field is disseminated widely to researchers, clinicians, and students worldwide. With a commendable Q1 ranking in multiple categories including Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, it appeals to a diverse readership, positioning itself at the forefront of research in biochemistry and medicine. It boasts an impressive Scopus rank, where it excels in areas such as Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, making it an essential resource for those looking to deepen their understanding of lipid biology and its clinical applications. Researchers can share and access findings that have significant implications for public health and disease prevention, emphasizing the journal's commitment to fostering innovation and collaboration in the scientific community.

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, published by Elsevier Science Ltd, is a prestigious academic journal dedicated to advancing the knowledge and understanding of the intricate relationships between nutrition, metabolism, and cardiovascular health. With an impressive HIndex and a consistent trajectory of high-impact research, this journal occupies a commendable position in the academic landscape, achieving Q1 rankings in both Cardiology and Cardiovascular Medicine, as well as in Nutrition and Dietetics for the year 2023. The journal’s Scopus rankings further solidify its reputation, occupying top percentiles across various categories, making it an essential resource for researchers, healthcare professionals, and students keen on exploring the latest findings in the field. Although it is not an open access journal, readers can access a wealth of knowledge that spans from 1996 to 2024, with articles that cover diverse topics in endocrinology, diabetes, and metabolism. By disseminating groundbreaking research and reviews, NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES aims to foster innovation and evidence-based practices that contribute to improved health outcomes worldwide.

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.